A key difference between academics and politicians was illuminated for me by the fore word of a special issue of a drug journal presenting "A Canadian Perspective" (Mitchell 1991). A "Forward" (sic) appeared by the Honorable Perrin Beatty, then Minister of National Health and Welfare. What may have seemed like a missed typo actually epitomized the great gulf between the academic and political forums. Academics are concerned with words, and thus with "words that go before," but policy-makers are interested with "what goes onward," with progress, with action steps. As this paper will demonstrate, it takes more then bringing the respective practitioners together between two covers, or in one committee room, to bridge this gap.
This paper will focus on the role of sociology and its allied social research disciplines in Canada's 25-year drug policy debate. In the tradition of Alfred Lindesmith (1965), sociologists have labored mightily in the volatile inter-disciplinary context that has attempted to bring about significant drug policy reform since the first upsurge of youthful illicit drug use in the 1960s. Research, writing, and socio-historical analysis have been extensive from the Le Dain Commission (1969-1973) onwards. Even political engagement in royal commissions and parliamentary hearings has not been neglected. Yet the result has been, as of June 1996, a new Canadian drug law that has been virtually untouched by this professional activity and scholarly output. The Controlled Drugs and Substances Act (CDSA) is a throwback to the 1920s, a revamped Narcotic Control Act, based on myths and preconceptions about drugs and their evil effects on users. The perpetuation of demonstrably inaccurate claims will continue to justify a punitive moral crusade against a largely undifferentiated target and support the institutional drug control bureaucracy with its drug war mentality (Foreword, Giffen, Endicott & Lambert 1991).
This paper will trace the many contributions of Canadian sociologists, and their disciplinary allies — mainly criminologists and anthropologists — to drug policy-relevant research. Along with colleagues from different specialities, sociologists have grappled with the thorny issues of addiction and social control, and have produced a treasure trove of scholarship perhaps unmatched in any other country on this topic (much of it collected in Blackwell & Erickson 1988). Specific drug policy initiatives will be examined, with attention to the articulation of knowledge during the more recent legislative debates. Given the final outcome of this process, the question of why politicians and other policy-makers in Canada have resisted the "enlightenment" provided by the available scholarship and expertise will be considered. Also noted will be the often greater attention paid to this work in other countries. Finally, I shall offer a necessarily speculative account of the possible positive impact of sociological input on society and the community more generally, despite its invisibility in the formal law and policy approach of the Canadian government.
As a caveat, please be aware that the selection of the work of specific sociologists and other colleagues shall be illustrative rather than comprehensive. I wish to highlight key contributions, and may neglect some authors and publications. This is a more personal piece of writing than is usual in academic discourse, and is of necessity dictated by my own contacts and exposure in over 20 years in the drug policy field. My primary aim is to make others aware of significant applied research and policy advances by their Canadian sociological colleagues. I also seek a lesson for the future of sociology from this particular example.
Sociologists at Work: A Legacy of Drug Policy Scholarship, 1965-1996
The first investigations pre-dated the Le Dain Commission launched in 1969. Shirley Cook, a graduate student in the Department of Sociology at the University of Toronto, utilized extensive archival footage to analyze the origins of the Canadian narcotic laws in 1908 through to their consolidation in the 1920s (Cook 1969). The overall project, under the direction of P. James Giffen, eventually resulted in the publication of Panic and Indifference: The Politics of Canada's Drug Laws, a massive and detailed tome in the sociology of law (Giffen et al. 1991). While identifying the focus of the original anti-opium statute as rooted in antipathy toward a racial minority (i.e., Asians) the authors also demonstrated that the persistence and expansion of the narcotic laws required further explication than that provided by a conflict or consensus model of lawmaking. Their interpretation was that Canada had experienced waves of drug scares, based on prejudice and misinformation, aggravated by the media, and exploited by politicians. When drug panics are combined with the central role of bureaucratic lawmakers and enforcers at the centre of political power in the federal ministries of health and justice, a change-resistant monolith is made possible (see also Goode and BenYehuda 1994).
Along with this social-historical scholarship, empirical studies of drug users also began in the late 1960s, in response to the emerging "drug problem" among youth of that era (Erickson & Smart 1980). The Le Dain Commission initiated the first national drug use surveys, under the leadership of Dr. Ralph Miller and a team of assistants, many of whom were or became sociology professors (e.g., Lynn McDonald, Judith Blackwell, Florence Andrews Kellner) or law professors and practitioners (e.g., Robert Solomon, Melyvn Green). A still ongoing series of student surveys by the Addiction Research Foundation of Ontario commenced in 1968, and a number of smaller, regional surveys of special populations were also conducted in these early days. These have been supplemented with increasingly more sophisticated surveys at both the provincial and federal levels. Canada has thus developed a sophisticated database on the drug use pat- terns and correlates of its population (Health Canada 1995; Rootman 1988). This is important, in drug policy terms, because police records of arrest and seizures — more indicative of police activity and priorities than of actual drug use prevalence and trends — can be balanced by these more objective indicators (Adlaf, Smart & Walsh 1993). For
example, we know that in Canada most illicit drug use peaked about 1979 and declined thereafter; moreover, levels of cocaine use never could be justifiably termed an epidemic, in contrast to the U.S. experience (Erickson, Adlaf, Smart & Murray 1994).
Members of Canadian sociology departments have also contributed to ethnographic or more community based studies of drug users. Stoddart (1988) has conducted unique participant-observational studies among heroin users in British Columbia. Early research on the emerging phenomenon of crack cocaine use was carried out in Toronto (Cheung, Erickson & Landau 1991). Studies of the street scene and homeless youth have focused on drug use in the context of personal and social wellbeing (Smart, Adlaf, Walsh & Zdanowicz 1992; McCarthy & Hagan 1996). Research on the impact of criminalization on cannabis users has failed to demonstrate a significant deterrent effect in the face of substantial individual and social costs (Erickson 1980; Erickson & Murray 1986).
These smaller studies facilitate the in-depth examination of drug use patterns and problems among heavier users than is possible with large-scale surveys, and reveal important information about risky practices and potentially effective interventions. Qualitative studies are also essential for understanding the meanings of social rituals in drug use that promote, or prevent, HIV transmission particularly among injection drug users. Such community studies often lead to the challenging or simplistic stereotypes about drug users and assumptions about addiction embedded in drug prohibitionist regimes. For example the supposedly "uncontrollable" property of cocaine use has failed to withstand the scrutiny of empirical research on users outside of treatment and correctional settings (Erickson & Weber 1994), findings now paralleled in studies in many countries (Harrison 1994; WHO 1995).
Canadian scholars have also produced over many years a number of policy analytic studies in the field of illicit drug policy. Quebec criminologist, Marie-Andree Bertrand, consistent with her pro-legalization minority reports for the Le Dain Commission (1972-73), has continued her critical stance on drug policy (Bertrand 1990). Again, there is great scope and variety illustrated by the following examples: Blackwell's assessments of international drug trafficking, and the Olympic steroid scandal (1988; 1991); Single's (1991) landmark study of marijuana decriminalization; Erickson & Cheung's (1992) examination of legal impacts of control policies; Beauchesne's (1997) integration of legalization and health promotion; Erickson's (1992) overview of Canada's drug strategy. Moreover, major books and critiques by non-sociologists have nevertheless been informed by the wide body of writing from this discipline (e.g., Alexander 1990; Boyd 1991; Mitchell 1990; Skirrow 1993). Nor has Canadian drug policy been neglected by sociologists from other countries (Jensen & Gerber 1993).
It can also be noted that many of the above-mentioned authors, and others, take part in the international meetings where drug policy is evaluated and debated. For example, a recent cannabis conference on law, policy and human rights in Bremen, Germany, placed Canadians on the speakers' roster (Erickson & Fischer 1995). Sometimes we are asked the anomalous question, (e.g., at an Australian harm reduction conference in 1992), as to how to explain the "success" of our drug policies compared to our neighbors to the south, since we are known to have much less of a drug problem than the USA. In one instance, the audience was soon disabused of the notion that Canadian laws and policies were much less punitive, leading one observer to conclude that "Canada's bite was worse than its bark" (McCoun, quoted in Erickson 1992) . Canadians also sit on advisory drug policy bodies and task forces in other countries as well as their own.
Canada, then, is not lacking in a strong research tradition critical of the past, harshly prohibitionist, drug policy for its ineffectiveness, high costs and destructive impacts. Moreover, much has been written more recently on the potential advantage of alternative policies, such as the public health-oriented approach of harm reduction, in providing a more suitable model for Canada (Erickson, Riley, Cheung and O'Hare 1997). Did any of this social research and policy analysis on the part of Canadian scholars, this distinctive sociological tradition of conceptualization and assessment, have an effect on new drug policy initiatives?
Entering the Legislative Arena — Policy Initiatives, 1992-1996
In this section, I shall consider the structure and content of the deliberations of the various parliamentary committees that considered the new drug law before it was passed in June 1996 (for specific details of the Controlled Drugs and Substances Act, see Fischer, Erickson & Smart 1996). Although it was first tabled by the Conservatives in June 1992, and went through three different numbers (C-85, C-7 and C-8) and two different names (first the "Psychoactive Substances Control Act," then the "Controlled Drugs and Substances Act") before being passed by the Liberal government four years later, the basic features of the law remained unchanged (Fischer 1997). In my role as senior scientist with the Addiction Research Foundation (ARF), I attended three hearings as part of our delegation — two House of Commons subcommittees on health and one Senate session. Transcripts are available for all such deliberations, unless held on camera. These meetings are also, in principle, open to the public, though usually space is somewhat limited. Specific institutions, groups and individuals may be asked to make a submission, and again in principle, anyone can request standing and a slot in the hearings. (That this does not always meet with a positive response is illustrated by the reception given to a group of drug policy scholars, attending the Learned Societies' meeting in Ottawa in 1992, who offered to provide input if desired to the C-85 House sub-committee that had just been convened — the offer was refused).
The significance of the new drug legislation is underlined by the fact that no substantive changes had occurred to the previous law, the Narcotic Control Act [NCA], since 1961, except for a minor penalty modification in 1969. While the Le Dain Commission had recommended removal of the simple possession offence for cannabis and other modifications (Le Dain 1972; 1973) no legislative action directly resulted. The only other intervening proposal was a bill to move cannabis from the NCA into the sister criminal statute, the Food and Drugs Act, which was introduced in 1974 and died on the order paper of Parliament in 1976 (Erickson 1980). Essentially then, Canada's drug law had remained unchanged since the 1960s and drug policy issues had been quiescent in the post-Le Dain era (Erickson 1992). In the interim, a considerable body of relevant research and analysis had emerged, during the 1970s and 1980s, that might have been expected to provide the basis for a new assessment of Canada's illicit drug "problem" and an appropriate social and legal response.
The first message delivered by government officials responsible for Bill C-85 at the (Conservative-dominated) committee was that "this was not a fundamental reassessment of Canada's drug laws ... [but a bill whose purpose was to] primarily consolidate existing legislation" (Minutes, May 1993). Given the tight time frame originally imposed on this committee — two weeks to hear witnesses, make recommendations and report back to Parliament — it seemed clear that no in depth examination would be possible. Nevertheless, the lack of even superficial background knowledge before the committee was illustrated by this interchange: A Member of Parliament asked a witness from the Canadian Medical Association, "Am I wrong the United Nations has said that Canada is the number-one illegal drug misusing country on the face of the earth?" (Minutes, May 25, 1993). When the witness was unable to shed any light on this allegation, the Member continued: "Most of us think it's the United States or Colombia or someplace, but I gather that the UN has said that Canada is actually the country with the greatest amount of illegal drug use, at least among the industrialized democracies."
The later transcripts indicated that the committee was never provided with any clarification on this question, nor with any trend data or detailed evidence from even the governments's own surveys or other sources about the actual extent of illicit drug use in Canada. The quoted reference was undoubtedly to a preceding, prominent news story in one of Canada's leading national papers (Globe & Mail, April 17, 1992, A1-A2). This story reported Canada's high recorded drug (mainly cannabis) offence rate, compared to other countries, i.e., a measure of police arrest activity, not an indicator of the prevalence of drug use or problems (Erickson & Cheung 1992, 257). The apparent basis on which this subcommittee on health was prepared to speed the new legislation through was a totally incorrect assumption about Canada's number-one global status in illicit drug abuse!
Very few witness groups were called by the C85 committee, and some of those who were had so little time to prepare that they declined. Most who did testify were representing professional groups with narrowly defined interests (e.g., Canadian Pharmaceutical Association; Non-prescription Drug Manufacturers Association). It fell to the ARF delegation to raise the more general drug policy issues, to express concern for the criminalization of users and the punishment of addicts, and also to suggest that the bill would be unlikely to reduce harm to the individual or society. This infusion of expert opinion, while welcomed by the NDP and Liberal critics on the committee, was not popular with the Conservative members: "I've always thought your organization was helpful in that intent [helping the police, helping the prosecutor]. Today I'm almost thinking, am I hearing correctly. You're almost not saying that and I don't think that's what you intend not to say" (Minutes, May 27, 1993).
Bill C-85 died when the election was called and the Conservatives lost office. When the identical bill was reintroduced by the Liberals, as C-7, in 1994, a familiar theme quickly emerged. Now the (Liberal-dominated) subcommittee on health heard again that this was a "housekeeping" bill, and an M.P. proclaimed, 'This bill is not a policy
It's really tidying up some of the loose ends we've had hanging around" (Fry in Minutes, May 10, 1994). This round, the C-7 committee met for many more sessions, over a longer period, and heard far more witnesses. ARF witnesses provided a more research-based presentation than it had for the previous committee, and continued to reiterate its key point that a full-scale policy review should take place before any new legislation was introduced (Minutes, May 10, 1994). There was much more spirited, and informed criticism of C-7 than had occurred with C-85, to the extent that ARF now occupied a middle ground while positions promoting public health (Neil Boyd; Toronto Public Health Dept.) and favoring legalization were introduced (Anti-Prohibitionist League of Quebec). Of course, voices of support for the legislation, from the RCMP and the Canadian Association of Chiefs of Police, were also prominent.
Faced with a great deal of public criticism of Bill C-7, and also substantial opposition from within the Liberal caucus, there was a lengthy silence between the committee hearings of April-June 1994 and the re-introduction and passage of the Bill for third reading in the House of Commons on October 30, 1995 — Quebec referendum day. Minor amendments — including one that provided â summary-only cannabis possession offence for amounts of 30g or less of marijuana and 1g or less of hashish, but still providing for up to six months imprisonment — had been incorporated by the subcommittee. The essentially unchanged Bill was presented by its Liberal supporters (the only real opposition, the Bloc Quebecois, not being in the House that day) as transforming that "draconian Mulroney bill" (Szabo, in Hansard 1995) into "a more liberal policy with regard to harm reduction, rehabilitation and societal aspects of drug use" (Fry in Hansard 1995). Among the many long speeches supporting the Bill that day, it is instructive to quote from one at length to illustrate the verbal contortions required to present an innovative version of the status quo. Bill C-7 had now become "more than a housekeeping bill. It achieves a balance between the need for compassionate health and social components of drug use and the need to punish and deal with the criminal and violent aspects of drug use.... That said, it was not the government's intention that the Bill would alter or review existing drug policy.... Prohibition has had very limited success and very high cost.... It [C-7] is not a new policy and it is not even a big change, but it is an important shift in perspective" (Fry in Hansard 1995). The government members did recommend, however, that a policy review be conducted after the Bill was passed.
Before turning to the Senate's review of the Bill, it may be helpful to note briefly what the major features of this new law are (Fischer et al. 1996). As in its predecessor, the NCA, Schedule I continues to combine cocaine, morphine, heroin and a variety of opiates without distinction. Cannabis, however, has been placed in two separate schedules, depending on the amounts. Many feature of the NCA are retained: imprisonment is a sentencing option for all possession offences, and large additional fines are also possible; maximum penalties for importing and trafficking are still life imprisonment; extraordinary powers of police search and seizure remain (Solomon 1988). Several new features are present. Precursor drugs have been added to the schedules of prohibited substances (e.g., those used in the manufacture of a psychoactive drug). The police gain new powers, namely to sell drugs in "reverse sting" undercover operations; seizure provisions have been expanded; judges are enjoined to consider specific "aggravating" factors (e.g., violence, prior record, involvement of minors) when sentencing and provide specific reasons for not imposing imprisonment; and police entry of fortified buildings is facilitated. A feature of the original C-85 that provoked much resistance from the health food industry, namely that any unnamed and unanalyzed substance could be "deemed" to he included in the list of prohibited substances if it had a p'sychoactive effect, was deleted from the final form of C-7. The committee also added a vague clause [11 (1) ] encouraging "rehabilitation and treatment in appropriate circumstances" (Barnes in Hansard 1995). This package was proclaimed by the final Liberal speaker on October 30 to "put Canada in the forefront of leading the war on drugs from a perspective of harm reduction" (Alcock in Hansard 1995).
This might be an appropriate moment to digress to consider a perplexing question that has likely occurred to the reader, namely, what were the forces driving this Bill? This is not an easy question to answer, as the impetus seemed to be largely "behind the scenes," perhaps in the hands of Giffen et al.'s "bureaucratic lawmakers." What is known is that the Bill survived two governments, one Conservative, the other Liberal, considerable and even public opposition from within the Liberal government's own caucus, media scrutiny and criticism, the testimony of not insubstantial expert witnesses and interest groups — and did this without a public "champion" of the legislation. In fact, when I and other policy critics were called frequently by various media who were trying to set up debates on C-7, the complaint was always that they couldn't get anyone from Ottawa to defend the Bill! There was never a high-profile public spokesperson for the value of the drug bill, comparable to Alan Rock's championing of gun control legislation; there was in fact almost no public defence of C-7 at all. Vague references were made by the government members to pressure from the United States and visits from foreign delegations and international concerns that it be passed (Hansard 1995). Why this would carry the day for a new law that would have its major impact on Canadians is not clear. The explanation for the CDSA's persistence and eventual victory is a puzzle that still remains to be solved.
The final chapter in the passage of the new drug law took place in the Canadian Senate where it was reviewed by the Standing Committee on Legal and Constitutional Affairs. Hearings began in December 1995, were resumed in February 1996, and continued to clause-by-clause reading and eventual passage in June 1996. On its way to passing an essentially unchanged but re-titled Bill C-8, the Senate Committee heard from a wide array of witnesses, amassed a considerable body of research literature, and talked to the press about including a cannabis decriminalization provision. Indicative of the greater attention paid to social research was the reception of the submission by the Canadian Foundation for Drug Policy. This is an organization founded in 1992, largely in opposition to Bill C-85, by a core group of a dozen academics and policy analysts who had written and published widely on social and legal aspects of Canadian drug policy (most of whom are cited in this paper). This group's representatives spent a lot of time with the committee, and were asked at the end to provide specific recommendations and amendments to the Bill, with supporting documentation — the only group asked to do so (Senate, Minutes, Dec. 14, 1995). Ultimately, the Committee recommended a policy review, set out broad guidelines for complete reassessment of the Government's approach (emphasizing research, legal analysis and models from other countries as well as Canada), and passed the Bill without major changes. The Chair of the Committee, Senator Sharon Carstairs, in a subsequent interview on CBC's "As it Happens," indicated she was in favor of marijuana decriminalization, but the Senate overall hadn't been exposed directly to the research and therefore could not support a policy change of that magnitude. Hence the CDSA awaits only proclamation, sometime in the autumn of 1996, to become the law of the land.
The Standing Committee on Health of the House of Commons quickly took action to initiate a review of "Policies on the Misuse and Abuse of Substances" (Standing Committee Minutes, June 1996). The terms of reference for the Committee included an assessment of the harmful impacts of both legal and illegal drugs, and emphasized demand reduction through the traditional means of education, prevention, treatment and rehabilitation. These terms bore little resemblance to the Senate's more far-reaching recommendations regarding a policy review that would encompass the development of a national harm reduction policy and an examination of alternative control models. Issues raised by many of the earlier presenters' research — criticism of the effectiveness of the supply side tactics of enforcement and imprisonment, and the high health and social costs of continued criminalization of illicit drug users — were to be left untouched. Submissions were invited from many of the previous cast of witnesses, and hearing were to begin in October 1996 and be completed in June 1997. It would take the most incurable optimist to expect any significant changes to the existing CDSA or to the overall direction of Canadian drug policy from such a review.
So Much Research — So Little Impact: Why?
The broader question of why Canadian drug policy is so resistant to change is a perplexing one, but not our major concern here. We can note, however, that some developed, western democracies with traditional "hard-line" prohibitionist policies have been reexamining them of late (e.g., Australia, Germany) while others, the USA in particular, remain vigorously committed to the war on drugs (Dupont 1996; Erickson & Butters, forthcoming) . In time, cross-national research may unravel some of the complexities of differing national drug policies, their determinants, and the factors that foster openness and resistance to change. Until then, we can only wonder if there is something unique about Canada and its approach to drug policy matters. Our more immediate concern is with the neglect of relevant social research within our own national boundaries.
While our interpretations are necessarily speculative, some general themes seem to emerge from this latest episode of drug policy-making in the 1990s. First, what are the interests and needs of the politicians themselves? What can they gain (and lose) by initiating reform of the drug laws? With public opinion divided on the best course to pursue, change from the status quo is best expressed as a "lose-lose" situation. This was articulated in many of the committee hearings, especially in reiterating that this was a "housekeeping" bill only. Whether the public is, in fact, as opposed to reform as the policy-makers seemed to think is a separate issue — one they were not inclined to pursue, relying instead on their perceptions and occasional citation of vociferous anti-drug crusader testimony and literature. A related point, made in other contexts, has been that politicians are happy to embrace research that supports what they have already decided to do. In this instance, while the weight of research favored reform, the pre-determined rejection of change in the Bills themselves (C-85, C-7, C-8) and their support from federal drug bureaucrats and Canada's Drug Strategy (Fischer 1997) did not create a receptive climate for "evidence-based" input to the process. If research had demonstrated the effectiveness of deterrence, and the great success of existing policies in preventing drug abuse, for example, it might have been more welcome. As it was, the perception of negative (or at least divided) public opinion on reform and the generally critical nature of research findings at odds with the preferred course of action, may have contributed to their lack of influence.
A second possible factor is the cultural devaluation of science and expert knowledge and its diminished role in government decision-making. This social process has been much discussed in academic circles in recent years, and will not be elaborated here, but it can be noted that examples abound in the drug policy arena. The Mulroney government abolished the Law Reform Commission of Canada, at the time in the midst of an extensive drug policy review (Erickson 1992). The Canadian Centre on Substance Abuse, providing an independent research and policy analysis function for the federal government, was cut to the bone in the 1996-97 budget, in preparation for its final demise. As already described above, the House of Commons subcommittees sitting on the new Bills had no research staff, did not solicit research input, and were refractory at times to what empirical evidence made its way into their deliberations. This is in sharp contrast to the Le Dain Commission, with its large research staff and budget, and summaries of available knowledge in its landmark reports (Le Dain 1972-73). (As a parenthetical note, it would also be interesting to know the characteristics of the current politicians and policy-makers themselves, especially their own educational and professional backgrounds, to match with an impression that they seemed less well-equipped than their previous counterparts to critically evaluate the sorts of information that they were receiving.) Beyond the possible decrease in receptivity to science, what this implies is the decline in, and lack of, mechanisms to transmit social research findings in a useful way for the policy objectives — no agencies, no bureaucratic support structure, and hence no role incumbents, with background and sophistication in grasping and relaying pertinent information to elected representatives. This might be combined with a greater tendency of elected representatives to rely on their own interpretation of information, and to be less receptive to expert opinion, than in the past. Thus, if this scenario has validity, the impact of available research knowledge would be seriously compromised.
Another suggestion is that there has been a continuing trade-off between more liberal policies on alcohol and tobacco (e.g., the lowering of cigarette taxes) and the need to be "tough" on illicit drugs. This is the legacy of this century's insistence on a sharp legislative dichotomy between legal and illegal drugs (Murray 1988; Erickson 1996). In contrast to the widespread, highly promoted and socially acceptable use of alcohol and tobacco for most of this century, illicit drug users provide the "easy enemy" (Christie 1993) for vilification and outsider status. There is a paradox here, with Canada's global recognition as a pioneer in health promotion and a reputation for tolerance and compassion (e.g., policies on multi-culturalism, refugees, as well as non-punitive responses to homosexuality and abortion), coexisting with continued insistence on harsh criminalization measures that punish drug addicted individuals and that generate high levels of both profits and violence in the drug trade. The persistence of the "dope fiend" mythology suggests a Durkheimian interpretation to maintain a moral consensus on the unacceptability of all illicit drug use behaviors. There is also an increasingly unpleasant underside to the enforcement of Canada's drug laws against visible minorities, a path well-travelled and documented in the USA, and more recently in Ontario (Blumstein 1993; Chambliss 1994; Ontario, Commission on Systemic Racism 1995). As sociologists, the mission of examining the forces that help to maintain stability in a society, as well as those that put the interests of some groups above others, can also help to identify important areas of social justice to be addressed in the policy process. Unfortu nately, the latest round of drug policy deliberations were almost completely resistant to warning signs about the social, racial and cultural implications of maintaining allegiance to the policies and practices of an aggressive drug prohibition.
Given the negligible impact of social research on Canadian drug law and policy in the 1990s, it might appear that sociologists would be advised to concentrate on providing scholarly explanations, in the landmark tradition of Giffen et al. (1991) rather than becoming directly involved in the policy forum. Yet, as someone who might be said to have wasted a lot of time in preparing for and attending government meetings, to no avail insofar as significant changes in drug law and policy are the standard, I find myself unwilling to give up. What I see as the more positive impact of these various policy-directed efforts by many colleagues as well as myself is the difficult-to-gauge influence on the members of the Canadian community more generally. Through media involvement, teaching courses, and providing public access to the research base on drug policy in a variety of ways, it is possible that the future may be shaped in a way that profits from this knowledge. For example, a number of scholars provided background, as well as on camera presence, to the CBC "Nature of Things" special on drugs and harm reduction in 1991-92. This show was a profound departure from the usual US-dominated drug war fare, and was well received according to the usual indicators of TV success. (A sequel is in preparation.) ARF collaborated with TV Ontario in 1994-95 to provide a critical and fact-based series on "Myths and Realities of Substance Use." These efforts, along with countless op-ed pieces, letters to editors, "backgrounders" and short interview clips, all take considerable time and effort away from conventional academic publication pursuits, but reach out to a much wider audience than is available within university corridors.
I suggest that sociologists should not abandon their forays directly into political forums, when such opportunities are presented, but also should strategize around achieving greater public availability and exposure to the hard-earned knowledge generated by social research efforts. Energy could be focused on improving skills in communicating research initiatives and results to non-specialist audiences. Perhaps in this way, and with careful assessment of the actual process and its successes and failures across a wide range of policy topics, we shall be more able to play an effective role in the future of Canadian society. Another chapter in drug policy may yet be written.
Patricia Erickson, PhD, is a professor in the Department of Sociology, University of Toronto, and senior scientist at the Addiction Research Foundation. Erickson has been awarded DPF's 1996 Alfred E. Lindesmith Award for Achievement in the Field of Scholarship. Send correspondence to: 33 Russell Street, Toronto, Canada, M5S 2S1.
Adlaf, E.M., R.G. Smart and G.W. Walsh. 1993. Ontario Student Drug Use Survey, 1977-93. Toronto: ARE
Alexander, Bruce. 1990. Peaceful Measures: Canada's Way Out of the War on Drugs. Toronto: University of Toronto Press.
Beauchesne, L. 1997. "Legalization of drugs: Responsible action toward health promotion and effective harm reduction strategies." In Erickson, Riley, Cheung & O'Hare, eds.
Bertrand, M.A., 1990. "Beyond Antiprohibitionism." Journa/ of Drug Issues 20(4): 533-542.
Blackwell, J. and P.G. Erickson, eds. 1988. Illicit Drugs in Canada: A Risky Business. Toronto: Nelson Canada.
Blackwell, J. 1988. "Canada in a global setting." In Blackwell and Erickson, eds.
Blackwell, J. 1991. "Discourses on drug use: The social construction of a steroid scandal." Journal of Drug Issues 21(1): 147-164.
Blumstein, A. 1993. "Making rationality relevant." Criminology 31(1): 1-16.
Boyd, N. 1991. High Society: Legal and Illegal Drugs in Canada. Toronto: Key Porter.
Chambliss, W. 1994. "Policing the ghetto underclass: The politics of law and law enforcement." Social Problems 41(2): 177-194.
Cheung, Y.W., P.G. Erickson and T Landau. 1991. "Experience of crack use: Findings from a community based study in Toronto."Journal of Drug Issues 21(1): 121-140.
Christie, Nils. 1993. Crime Control as Industry. New York: Routledge.
Commission on Systemic Racism in the Ontario Criminal Justice System. 1995. "Report of the Commission on Systemic Racism in the Ontario Criminal Justice System." Toronto: Queen's Printer.
Cook, S. 1969. "Canadian narcotics legislation, 1908-23: A conflict model interpretation." Canadian Review of Sociology and Anthropology 6(1): 36-46.
Dupont, R.L. 1996. "Harm reduction and decriminalization in the United States: A personal perspective." Substance Use and Misuse 31(14): in press.
Erickson, P.G. 1980. Cannabis Criminals: The Social Effects of Punishment on Drug Users. Toronto: ARF Books.
1992. "Recent trends in Canadian drug policy: The decline and resurgence of prohibitionism." Daedalus 121 (summer): 239-267.
1996. "The selective control of drugs."
Pages 59-77 in B. Schissel and L. Mahood, eds., Social Control in Canada. Don Mills: Oxford University Press.
Erickson, P.G., E.M. Adlaf, R.G. Smart and G.F. Murray. 1994. The Steel Drug: Cocaine and Crack in Perspective, 2nd ed. New York: Lexington Books.
Erickson, P.G. and J. Butters. forthcoming. "The emerging harm reduction movement: The de-escalation of the war on drugs?" In E. Jensen and J. Gerber, eds., The New War on Drugs. AACJS Press.
Erickson, P.G. and Y.W. Cheung. 1992. "Drug crime and legal control: Lessons from the Canadian experience." Contemporary Drug Problems 19 (summer): 247-277.
Erickson, P.G. and B.F. Fischer. 1995. "Canadian cannabis policy: The impact of criminalization, the current reality and future policy options." Presented at the international symposium, Cannabis Policy, Criminal Law and Human Rights, Bremen Germany.
Erickson, P.G. and G.F. Murray. 1986. "Cannabis criminals revisited." British Journal of Addiction 81(1): 77-81.
Erickson, P.G., D. Riley, Y. Cheung and P. O'Hare, eds. 1997. Harm Reduction: A New Direction for Drug Policies and Programs. Toronto: University of Toronto Press (in press).
Erickson, P.G. and R.G. Smart. 1980. "Canada." In S. Einstein, ed., The Community's Response to Drug Use. New York: Pergamon.
Erickson, P.G. and T. Weber. 1994. "Cocaine careers, control and consequences." Addiction Research 2(1) :37-50.
Fischer, B. 1997. "The battle for a Canadian drug law: A legal basis for harm reduction or a new basis for prohibition?" In Erickson, Riley, Cheung and O'Hare, eds. In press.
Fischer, B., P.G. Erickson and R.G. Smart. 1996. "The new Canadian drug law: One step forward, two steps backward." International Journal on Drug Policy 7(3): in press.
Giffen, P., J. S. Endicott and S. Lambert. 1991. Panic and Indifference: The Politics of Canada's Drug Laws. Ottawa: CCSA.
Goode, E. and Ben-Yehuda, N. 1994. Moral Panics: The Social Construction of Deviance. Cambridge: Blackwell.
Hansard. 1995. Debates, House of Commons, Oct. 30, 1995.
Harrison, L. 1994. "Cocaine using careers in perspective." Addiction Research 2(1): 1-20.
Health Canada. 1995. "Canada's Alcohol and Other Drugs Survey: Preview." Canada's Drug Strategy. Ottawa.
House of Commons. 1993. Minutes of the Subcommittee on Health.
1994. Minutes of the Subcommittee on Health.
1996. Minutes of the Standing Committee on Health.
Jensen, E. and J. Gerber. 1993. "State efforts to construct a social problem: The 1986 war on drugs in Canada." Canadian Journal of Sociology 18 (4) : 453- 462.
Le Dain Commission. 1972. Cannabis. Ottawa: Queen's Printer.. 1973. Final Report.. Ottawa: Queen's Printer.
Lindesmith, A.R. 1965. The Addict and the Law. Bloomington: Indiana U. Press.
McCarthy, B. and J. Hagan. 1996. "Making it: Work and alternative school in the transition from homelessness." In B. Galaway and J. Hudson, eds., Youth in Transition: Perspectives on Research and Policy. Toronto: Thompson Educational Publishing.
Mitchell, C.N. 1990. The Drug Solution. Ottawa: Carleton University Press.
1991. "Guest Editor's Introduction." Journal of Drug Issues 21(1): 9-18.
Murray, G.F. 1988. 'The road to regulation." In P.G. Erickson and J. Blackwell, eds.
Rootman, I. 1988. "Epidemiologic methods and indicators." In P.G. Erickson and J. Blackwell, eds.
Senate. 1995. Minutes of the Legal and Constitutional Affairs Committee.
Single, E.W. 1991. "The impact of marijuana decriminalization : An update." Journal of Public Health Policy 10(4): 456-466.
Skirrow, Jan. 1993. "Politics and the war on drugs." International journal of Drug Policy 4(4): 194-201.
Smart, R.G., E.M. Adlaf, G.W. Walsh and 1M. Zdanowicz. 1992. Drifting and Doing: Changes in Drug Use among Toronto Street Youth. Toronto: ARE
Solomon, R. 1988. "The noble pursuit of evil: Arrest, search and seizure in Canadian drug law." In RG. Erickson and J. Blackwell, eds.
Stoddart, K. 1988. 'The enforcement of narcotics violations in a Canadian city: Heroin users' perspectives on the production of official statistics." In RG. Erickson and J. Blackwell, eds.
World Health Organization (WHO). 1995. International Report of Country Profiles on Cocaine. Geneva: Programme on Substance Abuse.